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INTRODUCTION 
The metal/ metal oxide NPs exhibit novel and im-
proved physical, chemical and biological properties 
due to their larger surface area to volume ratios, nano-
scale dimensions and random motion. These NPs may 
also exhibit potential antimicrobial properties particu-
larly the ZnO NPs which hold considerable attention 
due to their unique catalytic antibacterial, antifungal 
and antiviral activities (Shrivastava et al., 2015). The 
NP synthesis protocols are as varied as the synthesized 
NPs spanning over physical, chemical and microbial 
methods. However, the microbial approach is most 
preferred due to involvement of less amount and types 
of chemicals and hence being more eco-friendly. The 
reports of synthesis of ZnO NPs using microbes like 
bacteria Aeromonas hydrophila (Jayaseelan et al., 
2012), fungal filtrates of Aspergillus terreus (Baskar et 
al., 2013) and yeast Candida diversa strain JA1 
(Chauhan et al., 2014) are known. The incubation with 
cell free or cell based extracts of microbes are espe-
cially recommended over higher eukaryotes as it ren-
ders ease of handling and easy genetic manipulation. 
The morphology and size of NPs can be controlled by 
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altering the reaction time and by using different bio-
templates (extracellular biomacromolecules from bac-
teria, fungi and yeast) and metal salts. The synthesis of 
spherical shaped ZnO NPs with size ranges between 20
-40 nm using zinc acetate and spherobacterium Strep-
tococcus thermophilus has been reported (Zhou et al., 
2007). Similarly, another report on the use of probiotic 
bacteria Lactobacillus plantarum VITESO7 with zinc 
sulphate as metal salt precursor resulted in synthesis of 
spherical 7-17 nm ZnO NPs (Selvarajan and Mohanas-
rinivasan, 2013). Fungal filtrates of Alternaria alter-
nata synthesized ZnO NPs of average size of 75 nm by 
using zinc sulphate solution (Sarkar et al., 2014).  
These NPs have a wide range of applications in phar-
maceutics, paint and cosmetics industry. Moreover, 
ZnO is approved by FDA (Food and drug administra-
tion) to be used in sunscreens due to its ability to re-
flect the skin deteriorating UV radiation (Jin et al., 
2009). The ZnO NPs have also been used in various 
textile, food and packaging industries owing to their 
antimicrobial properties probably because of produc-
tion of reactive oxygen species on the surface of NPs  
ZnO possesses antibacterial activity both in microscale 
as well as nanoscale formulations (Nair et al., 2009).  
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salts i.e. zinc acetate, zinc chloride and zinc sulphate as precursors with cell free extracts of Bacillus circulans 
MTCC 7906 (Bc7906) and Pleurotus florida (Pf). The synthesized NPs exhibited variation in their absorption peaks 
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respectively while the Bc7906 generated ZnO NPs showed peaks between 300-350 nm. A variation in ZnO NP  
morphology ranged from 50 to 120 nm in size and spherical, oval, cylindrical to trigonal anisotropic in shape by 
transmission EM. Further, the rough and corrugated surface topography of ZnO NPs was observed in Scanning EM. 
The % weight for Zn element surface composition as recorded by SEM-EDS was observed to be highest for zinc 
acetate (2.34%) and zinc sulphate (7.54 %) on microbial synthesis from Bc7906 and Pf respectively. The  
antimicrobial potential of the synthesized ZnO NPs on human pathogenic and plant beneficial bacteria was tested 
and it was observed to be highest for microbially synthesized ZnO NPs using zinc acetate (15 mm) and zinc  
sulphate (14 mm) as salt precursors @ 10 ppm. This is the first report on differential antimicrobial behavior of ZnO 
NPs on human pathogenic and plant beneficial microbes. 
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It also exhibits antisporicidal activity against high tem-
perature and pressure resistant spores (Sawai, 2003). 
The concentrations may vary from 3 mmol/l to 12 
mmol/l or higher concentrations to partially and com-
pletely inhibit the spore germination (Liu et al., 2009). 
The antimicrobial activity of ZnO NPs is higher par-
ticularly against water-borne pathogens namely Shig-
ella dysenteriae, Salmonella typhi, Vibrio cholera and 
Escherichia coli on doping with other semiconductor 
elements like cobalt (Oves et al., 2015). The ZnO NPs 
also possess antifungal activity against Aspergillus 
niger, A. fumigatus and A. aculeatus (Baskar et al., 
2013).The present study aims to compare the use of 
different salt precursors and two microbial extracellu-
lar extracts for the synthesis of ZnO NPs.  The antim-
icrobial activity of the synthesized NPs was then as-
sessed against both pathogenic and soil beneficial mi-
croorganisms. 
MATERIALS AND METHODS 
Chemicals: Analytical grade zinc acetate dihydrate, 
zinc chloride and zinc sulphate of Hi-Media Labora-
tory chemicals Pvt. Ltd, Mumbai, India and the com-
mercial zinc oxide nanoparticles were from Sisco Re-
search Laboratory Pvt. Ltd., Mumbai, India were used. 
Microbial cultures: Microbial cultures, Bacillus circu-
lans MTCC 7906, Escherichia coli, Pleurotus florida, 
Pseudomonas fluorescence, Rhizobium and Staphylo-
coccus aurens were obtained from Department of Mi-
crobiology, Punjab Agricultural University, Ludhiana, 
Punjab, India. Enterobacter cloacae MTCC 509 was 
procured from IMTECH, Chandigarh, India. 
Microbial synthesis of zinc oxide nanoparticles: The 
Bc7906 and Pf cultures were inoculated in nutrient 
broth and potato dextrose broth respectively and were 
incubated at 280C±20C for 48 hours in BOD incubator 
at 120 rpm. For the synthesis of ZnO NPs, 200 ml of 
cell free extract was incubated with 0.01 M zinc ace-
tate, zinc chloride and zinc sulphate respectively at 
280C±20C for 24 hours in shaking and static conditions 
till complete conversion of zinc acetate, zinc chloride 
and zinc sulphate into ZnO NPs. Simultaneously, the 
culture (cell free extracts of Bacillus and Pleurotus 
alone) and chemical (zinc salt(s) in distill water) con-
trols were also run along with the reaction flasks. 
Characterization of zinc oxide nanoparticles 
UV-Vis Spectroscopy: The samples were subjected to 
absorption spectroscopy with wavelength ranging from 
200 to 800 nm using Elico SL 218 Double Beam UV-
Vis Spectrophotometer. The absorbance was plotted 
against the wavelength to observe the characteristic 
peaks for synthesized nanoparticles. 
Scanning electron microscopy (SEM) and Energy 
dispersive spectroscopy (EDS): Morphology of syn-
thesized nanoparticles were characterized using SEM 
(Hitachi S-3400N) at 15 kV accelerating voltage in 
secondary electron imaging mode. Sample was pre-
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pared by placing 10µl of the sample on the stub which 
was vacuum dried overnight and later sputter coated 
with gold Ion sputter coater (model Hitachi E-1010). 
The surface elemental composition in percentage of 
atom and weight present on the sample was analyzed 
by EDS (Thermo Noran) attached to SEM by using 
higher probe current (50 to 60 microamperes and aper-
ture 2).  
Transmission electron microscopy (TEM):The 
nanoparticle size and structure measurements were 
performed on TEM (Hitachi H-7650) at 80 kV accel-
eration voltage in high contrast imaging mode. All the 
samples were sonicated for 20 minutes in a bath soni-
cator (Model- Equitron) to obtain even dispersion of 
the particles. Samples were drop casted by placing 10 
µl of the sample suspension on carbon/ formvar coated 
copper grid. The drop casted grids were air dried be-
fore imaging. 
Antibacterial assay 
Agar well assay (Modified Kirby-Bauer’s method, 
1966): Microbially synthesized nanoparticles were 
tested against three human pathogenic bacteria namely 
E. coli, E. cloacae MTCC 509 and S. aureus and three 
plant beneficial soil bacteria namely, Rhizobium sp., 
Azotobacter and Ps. fluorescens. Modified agar well 
diffusion method was used to check the antibacterial 
activity of the nanoparticles. Lawn cultures of the test 
microbes were prepared by spreading 100 µl of freshly 
prepared log phase bacterial culture on the petriplates 
containing nutrient agar. Uniform wells of 0.5 mm 
diameter were made using a gel borer. Concentrations 
of 2, 5, 8 and 10 ppm of the synthesized nanoparticles 
were added in these wells. Zinc acetate (0.01M), zinc 
chloride (0.01 M), zinc sulphate (0.01 M), bulk zinc 
oxide (0.01 M), cell free extract of Bc7906 and Pf 
were used as control. The commercially available anti-
biotics were used as control i.e. Ampicillin, Chloroam-
phenicol, Penicillin G, Streptomycin, Sulphatriad and 
Tetracycline for Gram-positive microorganism and 
Ampicillin, Gentamicin, Nalidixic acid, Cefalexin and 
Co-Trimoxazol for Gram-negative microorganisms. 
The plates were incubated at 37 0C for 24 hours for 
human pathogenic cultures and at 25 0C for soil benefi-
cial microorganism. After 24 hours, zone of inhibition 
(mm) were measured for each sample. 
Viable cell count of cultures using dilution spread 
plate technique (Throndsen, 1978): All the bacterial 
cultures were grown in nutrient broth medium for 24-
48 hours under shaking conditions (160 rpm on a ro-
tary shaker) for attaining log phase growth measured at 
600 nm on spectrophotometer using filter 3. Three 
concentrations of NPs i.e. 5 ppm, 8 ppm and 10 ppm 
were mixed in 50 ml nutrient broth in culture flasks 
and were ultra-sonicated for 15 minutes each. After 
sonication, 1 ml of bacterial culture aliquot was inocu-
lated in all the flasks and was mixed properly. Viable 
cell count on nutrient agar was enumerated at 0, 2, 4, 6 
and 8 hours after application respectively. 
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Statistical analysis: All the experiments were per-
formed in triplicates. The mean values were calculated 
and reported as the mean ± standard error represented in 
graphs. One way ANOVA using SPSS 20 software was 
conducted in agar well assay and two way ANOVA was 
done to determine the interaction among treatments and 
hours of incubation. 
RESULTS AND DISCUSSION 
UV-Vis spectroscopy: The microbially synthesized 
NPs under shaking as well as static conditions showed 
characteristic absorption maxima between 300-400 nm 
and 250-350 nm for Bc7906 and Pf extracts respec-
tively (Figs. 1 and 2). As ZnO NPs generally have 
                        Zone of inhibition (mm) 
Type of  
synthesis 
Type of salt 
precursor 
used 
Conc. of 
NPs used 
S. 
aureus 
E. 
coli 
E. cloacae 
MTCC 509 Rhizobium 
Ps.  
fluorecens Azotobacter 
Bacterial  
synthesis Zinc acetate 2 ppm 11 - - - - - 
    5 ppm 11 - - - - - 
    8 ppm 14 - 12 - - 12 
    10 ppm 15 - 14 11 - 13 
  ZnCl2 2 ppm 9 - - - - - 
    5 ppm 9 - - - - - 
    8 ppm 10 - - - - - 
    10 ppm 11 - 8 10 - - 
  ZnSO4 2 ppm - - - - - - 
    5 ppm - - - - - - 
    8 ppm 10 - - - - - 
    10 ppm 14 - - - - - 
Fungal syn-
thesis Zinc acetate 2 ppm - - - - - - 
    5 ppm - - - - - - 
    8 ppm - - - - - - 
    10 ppm 13 - - - - 12 
  ZnCl2 2 ppm - - - - - - 
    5 ppm - - - - - - 
    8 ppm - - - - - - 
    10 ppm - - - - - - 
  ZnSO4 2 ppm - - - - - - 
    5 ppm - - - - - - 
    8 ppm 10 - 10 9 - 18 
    10 ppm 13 - 12 10 - 21 
Commercial ZnO NP 2 ppm 16 8 9 10 11 22 
    5 ppm 20 9 11 14 12 24 
    8 ppm 22 9 13 15 13 25 
    10 ppm 24 11 14 17 15 28 
              C.D @5 % 2.06 NS 2.56 3.44 NS 4.34 
Antibiotics (concentration in mcg)                      Zone of inhibition (mm) 
Hexa G-minus S. aureus E. cloacae MTCC 509 E. coli Rhizobium Ps. fluorescens Azotobacter 
Ampicillin (10 mcg) - - - - 32 35 
Gentamicin (10 mcg) 21 12 19 25 30 36 
Nalidixic acid (30 mcg) - 27 - - 14 35 
Chloroamphenicol (30 mcg) 24 26 30 12 - 32 
Cefalexin ( 30 mcg) - - - - - 35 
Co-Trimoxazole (25 mcg) - 20 25 - 11 36 
Hexa G-plus   
Ampicillin ( 10 mcg) - - - 10 - 32 
Penicillin G (0.6 mcg) - - - - - 35 
Streptomycin (10 mcg) - - - - 23 31 
Sulphatriad (30 mcg) - - 14 22 12 35 
Tetracycline (25 mcg) 20 23 29 33 17 36 
C.D @ 5 % 2.31 2.91 2.90 3.70 2.89 NS 
Table 1. Antimicrobial activity of Zinc oxide nanoparticles microbially synthesized against human pathogenic and soil benefi-
cial microorganisms. 
Table 2. Zone of inhibition against test microorganisms for specific antibiotics. 
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  Zone of inhibition (mm) 
Controls E.coli E. cloacae MTCC 509 Ps. fluorescens 
ZnO Bulk 2ppm - - - 
5ppm - - - 
8 ppm - - - 
10 ppm - - - 
ZnCl2 2ppm - - - 
5ppm - - - 
8 ppm - - - 
10 ppm - - - 
Zinc acetate 2 ppm - 10 - 
5 ppm - 11 14 
8 ppm 13 15 14 
10 ppm 13 15 14 
ZnSO4 2 ppm - - - 
5 ppm - - - 
8 ppm 22 - - 
10 ppm 22 - - 
C.D @ 5 % 2.31 2.31 NS 
Table 3. Antimicrobial activity of chemical controls used against pathogenic microorganisms and soil beneficial microorganisms. 
Fig. 1. UV-vis spectra of ZnO NPs synthesized from cell free 
extract of Bc7906.  
Fig. 2. UV-vis spectra of ZnO NPs synthesized from cell free 
extract of Pf. 
Fig. 3. SEM images of ZnO nanoparticles synthesized from 
cell free extract of Bc7906 using (i) zinc acetate (ii) zinc 
chloride (iii) zinc sulphate as salt precursors. ZnO nanopar-
ticles synthesized from cell free extract of Pf using (iv) Zinc 
acetate (v) zinc chloride (vi) zinc sulphate as salt precursors.  
peaks ranging from 200-300 nm wavelength (Kumar 
and Rani, 2013), the absortion maxima for our NPs 
have shown a red shift. Similar peaks at about 340 nm 
and 374 nm have been reported for A. terrus (Baskar et 
al., 2013) and A. hydrophila synthesized ZnO NPs 
(Jayaseelan et al., 2012).  
Scanning electron microscopy (SEM): The ZnO NPs 
obtained by keeping microbial cell extracts with pre-
cursor salts under shaking conditions showed uniform 
size and shapes. Hence, these NPs were furthered used 
for the later characterization and antimicrobial activity 
tests. The SEM studies revealed synthesis of small size 
ZnO NPs existing in both homogenously monodis-
persed as well as in aggregated form (Fig.3). The SEM
-EDS analysis of the different ZnO NPs in X-ray spec-
trum mode showed characteristic peaks for Zinc (L 
(alpha) = 1.012 keV, Kα = 8.630 keV and Kβ = 9.570 
keV). It also gave % atom and % weight for the pres-
ence of zinc element which was highest (2.34 %) in 
zinc acetate precursor derived ZnO NPs as compared 
to other two salt precursors incubated with Bc7906 
culture (Fig.4). While the Pf  derived ZnO NPs from 
zinc sulphate as precursor had highest percent weight 
for Zn element (7.54 %) on their surface. Similar ob-
servation of signal peak for the presence of Zn element 
on the surface of ZnO NPs has been reported by 
Jayaseelan et al. (2012).  
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a) zinc acetate  
b) zinc chloride   
c) zinc sulphate  
d) zinc acetate   
e) zinc chloride  
f) zinc sulphate  
Fig. 4. SEM-EDS  spectral peaks of ZnO NPs synthesized from cell free extract of Bc7906 using (a) zinc acetate (b) zinc chlo-
ride (c) zinc sulphate as salt precursors. ZnO nanoparticles synthesized from cell free extract of Pf using (d) Zinc acetate (e) 
zinc chloride (f) zinc sulphate as salt precursors.  
A 
B 
             Zinc acetate     Zinc chloride                                             Zinc sulphate 
                  a) Zinc acetate                                         b) Zinc chloride                                             c) Zinc sulphate   
    Fig.5. Transmission electron micrographs of zinc oxide nanoparticles A) synthesized from Bc7906 and B) Pf 
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C.D @ 5 % A (Hours of incubation)= 0.017 B (Treatments)= 0.024 A×B= 0.053 
Fig. 6. Growth measurements for Rhizobium treated with zinc oxide nanoparticles A) Growth curve (Log cfu per ml) of Rhizo-
bium cultures B) Generation time growth curve against hours of incubation. 
C.D @ 5 %  A (Hours of incubation) = 0.019 B (Treatments) = 0.027 A×B = 0.06 
Fig. 7. Growth measurements for Ps. fluorescens treated with zinc oxide nanoparticles A) Growth curve (Log cfu per ml) of Ps. 
fluorescens  cultures B) Generation time growth curve against hours of incubation. 
  A 
  A 
  B 
  B 
A B 
C.D @ 5 %  A (Hours of incubation)= 0.0241 B (Treatments)= 0.0341 A×B= 0.076 
Fig. 8. Growth measurements for Azotobacter treated with zinc oxide nanoparticles A) Growth curve (Log cfu per ml) of  
Azotobacter cultures B) Generation time growth curve against hours of incubation. 
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C.D @ 5 %  A (Hours of incubation)= 0.016 B (Treatments)= 0.023 A×B= 0.051 
Fig. 9. Growth measurements for S. aureus treated with zinc oxide nanoparticles A) Growth curve (Log cfu per ml) of staphylo-
coccal cultures B) Generation time against hours of incubation. 
C.D @ 5 %  A (Hours of incubation)= 0.034 B (Treatments)= 0.047 A×B= 0.106 
Fig. 10. Growth measurements for E. cloacae MTCC 509 treated with zinc oxide  nanoparticles A) Growth curve (Log cfu per 
ml) of E. cloacae MTCC 509 B) Generation time against hours of incubation. 
A B 
A B 
A B 
C.D @ 5 %  A (Hours of incubation)= 0.031 B (Treatments)= 0.044 A×B= 0.098 
Fig. 11. Growth measurements for E. coli treated with zinc oxide nanoparticles A) Growth curve (Log cfu per ml) of E. coli  B) 
Generation time against hours of incubation. 
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Transmission electron microscopy (TEM): The re-
duction of all the three precursor zinc salts with the 
microbial cell free extracts under shaking condition 
generated oval to nearly spherical shaped NPs. How-
ever, the Pf extracts had the smallest size NPs (10-20 
nm) synthesized using zinc sulphate precursor (Fig.5). 
Other precursors on incubation with the microbial cul-
tures also yielded spherical shaped NPs. Thus the type 
of salt precursor has negligible effect on the morphol-
ogy of the microbial synthesized ZnO NPs unlike the 
wet chemistry synthesis where altered morphologies 
were obtained on basis of precursor salt used (Mayekar 
et al., 2014). Similar synthesis of spherical shaped NPs 
with size range between 30-63 nm has been reported 
by Meruvu et al. (2011). Kundu et al. (2014) have also 
reported synthesis of 100-200 nm ZnO NPs by actino-
bacteria Rhodococcus pyridinivorans NT2 in presence 
of ZnSO4 salt.  
Agar well assay: The commercial ZnO NPs @ 10 
ppm showed significantly higher antimicrobial activity 
(AMA) against all the test microorganisms. They 
showed maximum AMA against gram positive S. 
aureus with 24 mm followed by 14 mm zone of inhibi-
tion against E. cloacae MTCC 509. Lesser inhibition 
was observed against other gram negative pathogenic 
cultures like 11 mm only for E. coli. A higher AMA 
was observed as zone of inhibition against plant bene-
ficial microorganism with highest against Azotobacter 
(28 mm) and lowest against Ps. fluorescens (15 mm) 
followed by Rhizobium (18 mm). Zinc acetate derived 
Bc7906 incubated ZnO NPs formed under shaking 
conditions showed maximum AMA @ 10 ppm con-
centration against E. cloacae MTCC 509 (17 mm) fol-
lowed by S. aureus with 15 mm zone of inhibition 
(Table 1). Similar report of AMA of ZnO NPs at a 
higher concentration of 100 µg/ml against S. aureus 
with 14.52 mm zone of inhibition has been docu-
mented by Vani et al. (2011). Interestingly, these NPs 
exhibited lesser inhibition against gram negative plant 
beneficial rhizobacteria Rhizobium and Azotobacter, 
while no inhibition was observed against enterobacteri-
aceae member human pathogenic E. coli and plant 
probiotic pseudomonadaceae family member Ps. fluo-
rescens. Contrary to our results, ZnO NPs synthesized 
from A. hydrophila have been reported to inhibit E. 
coli (Jayaseelan et al., 2012) as well as had shown 
highest AMA against Ps. aeruginosa. The AMA of 
ZnO NPs synthesized from Pf using zinc sulphate as 
precursor showed maximum zone of clearance of 21 
mm against plant beneficial gram negative Azotobacter 
and 17 mm each against gram positive human patho-
genic S. aureus and gram negative E. cloacae MTCC 
509. These NPs had smaller inhibition zones against 
Ps. fluorescens and Rhizobium and exhibited no inhibi-
tion against E. coli. Hence, E. coli seems to be resistant 
against both types of microbially synthesized ZnO 
NPs. This may probably due to presence of some cap-
ping protein(s) non-homologous to E. coli cell surface 
ligands or other proteins. The chemical controls (Bulk 
ZnO and Zinc chloride) showed no inhibitory effect on 
any of the test pathogens and soil beneficial microor-
ganisms. Thus it could be ruled out that the lower con-
centrations of the ionic zinc (Zn2+) released by these 
compounds were lethal. Chemical control (Zinc ace-
tate) exhibited slight inhibitory activity against E. coli, 
E. cloacae MTCC 509 and Ps. fluorescens while zinc 
sulphate inhibited the growth of E. coli. Therefore, the 
chemical composition of the zinc salt utilized affects 
the AMA it renders as zinc acetate and zinc sulphate 
exhibited some inhibitory effect on the microbial 
growth. Some antibiotics showed better inhibition than 
the NPs such as Nalidixic acid and Chloroamphenicol 
with maximum zone of inhibition against E. cloacae 
MTCC 509. However, the concentrations being used 
were more in comparison to the nanoparticle concen-
trations used in this report. Strikingly, Cefalexin and 
ampicillin does not showed any inhibition against any 
of the pathogenic microorganisms. Diameter of zone of 
inhibitions by antibiotics against E. cloacae MTCC 
509, E. coli, S. aureus, Rhizobium, Ps. fluorescens and 
Azotobacter are presented in Table 3. Taking in ac-
count the size of the inhibition zone formed by these 
NPs, commercial ZnO NPs @ 10 ppm are more effec-
tive in terms of their potential as antimicrobial agents 
compared to microbially synthesized ZnO NPs at the 
same concentration probably due to faster ionization 
yielding Zn2+ ions leading to higher toxicity and even-
tually delay in cell growth followed by death. 
Growth of microbial cultures in broth supple-
mented with NPs. Various ZnO NPs synthesized us-
ing different salt precursors showed significant differ-
ence among their antimicrobial activity. Zinc acetate 
derived ZnO NPs generated from the cell free extract 
of Bc7906 and zinc sulphate derived ZnO NPs gener-
ated from cell free extract of Pf under shaking condi-
tions were selected further for broth-NPs interaction 
study to determine the extent of cell morphological 
alteration on incubation with ZnO NPs as well to de-
termine the variation in the generation time of the test 
microbes. The growth of Rhizobium in the presence of 
different ZnO NP concentration varied significantly. 
The rhizobial growth in control treatment without NP 
supplementation increased with the increase in hours 
of incubation. Rhizobium culture treated with commer-
cial ZnO NPs exhibited a concentration dependent 
decrease i.e. lowest log cfu per ml @ 10 ppm followed 
by 8 ppm and 5 ppm concentrations. The zinc sulphate 
derived ZnO NPs using Pf cell free extract @ 10 ppm 
showed the lower log cfu per ml as compared to other 
microbially synthesized ZnO NPs (Fig.6). Other NP 
inoculated cultures showed significantly lesser growth 
in broth media than the control Rhizobium culture. 
However, in all the ZnO treatments, growth was re-
tarded with increase in concentration of NPs. Genera-
tion time was observed to be highest by the Rhizobium 
culture inoculated with fungal derived ZnO NPs using 
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zinc sulphate @ 5, 8 and 10 ppm as compared to con-
trol as well as other treatments. In the absence of any 
NPs, Ps. fluorescens growth increased with increase in 
hours of incubation (Fig. 7). Incubation of Ps. fluores-
cens cells in the presence of all the ZnO NPs synthe-
sized using different salt precursors enhanced their 
growth in a time dependent manner with growth 
equivalent to control culture treatment. Thus, ZnO NPs 
even at higher concentration (10 ppm) have enhancing 
effect on Pseudomonas growth. But contrary to that, 
commercial ZnO NPs @ 5, 8 and 10 ppm have re-
tarded the growth of Ps. fluorescens with lowest log 
cfu per ml. The generation time determined after 8 
hours of incubation showed variation among the treat-
ments giving the evidence for results reported by the 
enumeration of viable cell count. The results indicated 
that the highest generation time was reported by com-
mercial ZnO NPs @ 5, 8 and 10 ppm treated Ps. fluo-
rescens cultures.   Similarly, growth of Azotobacter 
treated and untreated with NPs increased with time 
(Fig. 8). However, on incubation with commercial 
ZnO NPs @ 10 ppm maximum growth was curbed 
compared to other treatments. This may be attributed 
to higher rate of dissolution and formation of Zn2+ ions 
and hence greater toxicity of commercial ZnO NPs. 
The growth reported by the determination of genera-
tion time after 8 hours of incubation also showed the 
greater toxicity of commercial ZnO NPs @ 10 ppm 
giving the highest generation time as compared to con-
trol culture of Azotobacter.   ZnO NPs have an inhibi-
tory effect on S. aureus growth. Both microbially syn-
thesized and commercial ZnO NPs at 10 ppm concen-
tration have retarded the bacterial growth in compari-
son to other lower concentrations used. These treat-
ments @ 10 ppm were also reported to give highest 
generation time confirming the above stated results of 
growth inhibition.  
As depicted in Fig. 10, a significant decrease in growth 
of the control and ZnO NPs treated E. cloacae MTCC 
509 culture was observed. Highest growth inhibition 
was observed by both microbially generated ZnO NPs 
and commercial ZnO NPs @ 10 ppm giving lowest log 
cfu per ml and as well as highest generation time after 
8 hours of incubation in comparison to control treat-
ment. The decrease in growth exhibited NP concentra-
tion dependence. Chitra et al. (2013) have reported 
similar decrease in growth of E. coli and P. aeruginosa 
with increase in concentration of ZnO nanoparticles 
and maximum inhibition was obtained at 100 µg per 
ml concentration. The log cfu per ml of E. coli cells in 
presence of ZnO NPs was decreased with increasing 
concentration of NPs (Fig.11). However, this is not in 
consensus to the formation of no zone of inhibition in 
the agar well study. This signifies the higher potential 
of same concentration of ZnO NPs under aqueous sus-
pensions over agar gel embedded NPs. Here in this 
case, lowest log cfu per ml and highest generation time 
was reported by the E. coli culture treated with ZnO 
NPs synthesized from Bc7906 and commercial ZnO 
NPs @ 10 ppm in comparison to control culture after 8 
hours of incubation. Similar report of inhibition of E. 
coli by ZnO NPs in broth at 15 mM concentration has 
been documented by Paul and Ban (2014). Likewise, 
inhibition of growth of E. coli O157:H7 by application 
of ZnO NPs (@ 3 mmol/l) and @ 12 mmol/l or higher 
concentrations to completely inhibit the growth have 
been reported by Liu et al. (2009).   
Conclusion  
The microbially synthesized ZnO NPs had spherical 
morphologies with size ranging from 50 to 100 nm. 
Both bacterial and fungal derived ZnO NPs showed 
antimicrobial activity against the test human patho-
genic and plant beneficial microorganisms. The com-
mercial ZnO NPs exhibited higher bacterial cytotoxic-
ity showing 28 mm zone of inhibition @10 ppm 
against Azotobacter (a plant beneficial microorganism) 
as compared to microbially synthesized NPs. Hence, 
this differential toxicity of microbially generated ZnO 
NPs can be better utilized for developing novel  
agri-food commercial products keeping in view their 
lesser post application ecotoxicity issues observed as 
lesser or rather positive effect on plant beneficial rhizo-
bacteria. 
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